SIS-101-ADO Granted Orphan Drug Designation for Autosomal Dominant Osteopetrosis Type 2
Have you ever heard of the Orphan Drug designation? This designation, created through the Orphan Drug Act and granted by the U.S. Food and Drug Administration (FDA), is used to…